ADVANCES IN THALASSEMIA MANAGEMENT AND CHELATION THERAPY
Autosomal recessive thalassemias are a heterogeneous group of diseases characterized by hypochromic microcytic anemia, which develops as a result of defective synthesis of one or more of the hemoglobin (Hb) chains. It occurs when the Hb chain or chains are produced in small numbers or not at all. In...
Saved in:
| Main Author: | Barbaros Şahin Karagün |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-12-01
|
| Series: | Hematology, Transfusion and Cell Therapy |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2531137924029365 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
IRON CHELATION THERAPY IN THALASSEMIA SYNDROMES
by: Paolo Cianciulli
Published: (2009-06-01) -
CARDIAC FUNCTION AND IRON CHELATION IN THALASSEMIA MAJOR AND INTERMEDIA: A REVIEW OF THE UNDERLYING PATHOPHYSIOLOGY AND APPROACH TO CHELATION MANAGEMENT
by: Athanasios Aessopos, et al.
Published: (2009-07-01) -
New Perspectives on the Impact of Iron Chelation Therapy on the Gut Microbiome in Thalassemia Patients
by: Sara Deumić, et al.
Published: (2025-02-01) -
The Impact of Chelation Therapy on Hepcidin, Ferritin, and Fertility Hormones in Female with Beta Thalassemia Major
by: Heba Mohamed Hasan ALkatawe, et al.
Published: (2025-07-01) -
Application of Fuzzy AHP for Medication Decision Making in Iron-Chelating Medications for Thalassemia
by: Saeed Barzegari, et al.
Published: (2025-06-01)